First Analysis of HOVON-65/GMMG-HD4 Randomized Phase III Trial Comparing Bortezomib, Adriamycine, Dexamethasone (PAD) Vs VAD as Induction Treatment Prior to High Dose Melphalan (HD... von Sonneveld, P., van der Holt, B., Schmidt-Wolf, I.G.H., Bertsch, U., Jarari, L. el, Salwender, Hans-Jürgen, Zweegman, S., Vellenga, E., Schubert, J., Blau, I.W., Jie, GSK, Beverloo, B., Jauch, A., Hose, D., Schaafsma, R., Kersten, M.J., Delforge, M., de Weerdt, O., van der Griend, R., Wijermans, P.W., Martin, Hans, van der Velde, H., Lokhorst, Henk M., Goldschmidt, H.

Volltext

B152 First Analysis of HOVON-65/GMMG-HD4 Randomized Phase III Trial Comparing Bortezomib, Doxorubicin, Dexamethasone (PAD) vs. VAD as Induction Treatment Prior to High-dose Melphal... von Sonneveld, P, Eljarari, L, Salwender, H, Zweegman, S, Vellenga, E, Van Der Holt, B, Schmidt-Wolf, IGH, Bertsch, U, Schubert, J, Blau, IW, Jie, GSK, Beverloo, B, Jauch, A, Hose, D, Schaafsma, R, Kersten, MJ, Delforge, M, De Weerdt, O, Van Der Griend, R, Wijermans, PW, Martin, H, Van Der Velde, H, Lokhorst, HM, Goldschmidt, H

Volltext